This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Mallinckrodt, Cigna accused of scheming to fix Acthar prices

( May 26, 2021, 22:31 GMT | Official Statement) -- MLex Summary: A police benefits fund filed a complaint accusing Mallinckrodt and Cigna of conspiring to limit the distribution and output of Mallinckrodt’s Acthar Gel in order to raise prices. “With the price fixed, the Defendants then conspired and agreed among themselves and with other named and unnamed co-conspirators (including professionals) to market, promote and sell Acthar for unapproved uses and doses to the detriment of patients and payors of Acthar,” according to the complaint.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections